First AD

Second AD

Focusing on the complex pathophysiology of atopic dermatitis, Lindsay S. Ackerman, MD, FAAD, discusses the importance of looking beyond type 2 inflammation while treating patients.

Looking Beyond Type 2 Inflammation in Atopic Dermatitis

Video content above is prompted by the following:

With better understanding of the pathophysiology of atopic dermatitis, how important is to look beyond type 2 inflammation?

Atopic Dermatitis

INC-22-MDD0529 - /clinical/atopic-dermatitis

Atopic Dermatitis condition center page, audiences can find a variety of coverage mediums for medical news and updates, including articles, video interviews, podcasts, and breaking news on dermatitis research, treatment, and drug development.

Peer Exchange

HCPLive® Peer Exchange panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's care professionals.

Treatment Advances and Evolving Standard of Care in Atopic Dermatitis

Yale School of Medicine - Internal Medicine

HCPLive® Strategic Alliance Partnerships feature insights, opinions, and perspectives delivered from experts at our healthcare system and institution partnerships.

Strategic Alliance Partnership

Heterogenous Presentation of Atopic Dermatitis

Burden of Atopic Dermatitis and its Impact on Patient’s Quality of Life

Patient’s Goals and Atopic Dermatitis Treatment Selection

Talking to Patients about Atopic Dermatitis Treatment Response

Use of PRO in Atopic Dermatitis Clinical Practice

Incorporating Patient Preferences in the Treatment of Atopic Dermatitis

Changing Standard of Care in Atopic Dermatitis

Unmet Needs and Gaps in AD

JAK Inhibitors in Atopic Dermatitis

Safety Profile of JAK Inhibitors and their Use in Atopic Dermatitis

Monitoring Schedule for JAK Inhibitors in Atopic Dermatitis

Data from LEVEL UP Trial with Upadacitnib in Atopic Dermatitis

Long-term Safety of JAK Inhibitors in Atopic Dermatitis

Use of JAK Inhibitors and Systemic Treatments for Atopic Dermatitis

Treatment of Bio-Naïve Patients or Those Progressing on Topical or Biologic Atopic Dermatitis Therapy

Emerging Treatments for Atopic Dermatitis